Suppr超能文献

雌激素受体依赖性的糖皮质激素受体蛋白酶体降解与mdm2蛋白表达增加相关联。

Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.

作者信息

Kinyamu H Karimi, Archer Trevor K

机构信息

Chromatin and Gene Expression Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.

出版信息

Mol Cell Biol. 2003 Aug;23(16):5867-81. doi: 10.1128/MCB.23.16.5867-5881.2003.

Abstract

Glucocorticoids and estrogens regulate a number of vital physiological processes. We developed a model breast cancer cell line, MCF-7 M, to examine potential mechanisms by which the ligand-bound estrogen receptor (ER) regulates glucocorticoid receptor (GR)-mediated transcription. MCF-7 cells, which endogenously express ERalpha, were stably transfected with mouse mammary tumor virus promoter-luciferase (MMTV-LUC) reporter and GR expression constructs. Our results demonstrate that treatment with estrogen agonists (17beta-estradiol [E2], diethylstilbestrol, genistein), but not antagonists (tamoxifen or raloxifene), for 48 h inhibits GR-mediated MMTV-LUC transcription and chromatin remodeling. Furthermore, estrogen agonists inhibit glucocorticoid induction of p21 mRNA and protein levels, suggesting that the repressive effect applies to other GR-regulated genes and proteins in MCF-7 cells. Importantly, GR transcriptional activity is compromised because treatment with estrogen agonists down regulates GR protein levels. The protein synthesis inhibitor cycloheximide and the proteasome inhibitor MG132 block E2-mediated decrease in GR protein levels, suggesting that estrogen agonists down regulate the GR via the proteasomal degradation pathway. In support of this, we demonstrate that E2-mediated GR degradation is coupled to an increase in p53 and its key regulator protein Mdm2 (murine double minute 2), an E3 ubiquitin ligase shown to target the GR for degradation. Using the chromatin immunoprecipitation assay, we demonstrate an E2-dependent recruitment of ERalpha to the Mdm2 promoter, suggesting a role of ER in the regulation of Mdm2 protein expression and hence the enhanced GR degradation in the presence of estrogen agonists. Our study shows that cross talk between the GR and ER involves multiple signaling pathways, indicative of the mechanistic diversity within steroid receptor-regulated transcription.

摘要

糖皮质激素和雌激素调节许多重要的生理过程。我们构建了一种模型乳腺癌细胞系MCF-7 M,以研究配体结合型雌激素受体(ER)调节糖皮质激素受体(GR)介导的转录的潜在机制。内源性表达ERα的MCF-7细胞被稳定转染了小鼠乳腺肿瘤病毒启动子-荧光素酶(MMTV-LUC)报告基因和GR表达构建体。我们的结果表明,用雌激素激动剂(17β-雌二醇 [E2]、己烯雌酚、染料木黄酮)处理48小时可抑制GR介导的MMTV-LUC转录和染色质重塑,但雌激素拮抗剂(他莫昔芬或雷洛昔芬)则无此作用。此外,雌激素激动剂抑制糖皮质激素诱导的p21 mRNA和蛋白水平,这表明这种抑制作用适用于MCF-7细胞中其他GR调节的基因和蛋白。重要的是,GR转录活性受损,因为用雌激素激动剂处理会下调GR蛋白水平。蛋白质合成抑制剂环己酰亚胺和蛋白酶体抑制剂MG132可阻断E2介导的GR蛋白水平下降,这表明雌激素激动剂通过蛋白酶体降解途径下调GR。为此,我们证明E2介导的GR降解与p53及其关键调节蛋白Mdm2(小鼠双微体2)的增加相关,Mdm2是一种E3泛素连接酶,已被证明可靶向GR进行降解。使用染色质免疫沉淀试验,我们证明ERα在E2依赖的情况下被募集到Mdm2启动子,这表明ER在调节Mdm2蛋白表达中起作用,因此在雌激素激动剂存在的情况下增强了GR降解。我们的研究表明,GR和ER之间的相互作用涉及多个信号通路,这表明类固醇受体调节的转录机制具有多样性。

相似文献

2
Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
J Biol Chem. 2001 Nov 16;276(46):42714-21. doi: 10.1074/jbc.M106033200. Epub 2001 Sep 12.
4
Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.
Mol Cell Biol. 2002 Jun;22(12):4113-23. doi: 10.1128/MCB.22.12.4113-4123.2002.
7
Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
J Biol Chem. 2004 Mar 26;279(13):12020-6. doi: 10.1074/jbc.M312762200. Epub 2003 Dec 30.
9
DNA damage-induced MDMX degradation is mediated by MDM2.
J Biol Chem. 2003 Nov 14;278(46):45946-53. doi: 10.1074/jbc.M308295200. Epub 2003 Sep 8.

引用本文的文献

1
SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells.
Clin Exp Metastasis. 2024 Oct;41(5):747-764. doi: 10.1007/s10585-024-10294-2. Epub 2024 May 26.
2
Proteasome Inhibition Reprograms Chromatin Landscape in Breast Cancer.
Cancer Res Commun. 2024 Apr 16;4(4):1082-1099. doi: 10.1158/2767-9764.CRC-23-0476.
3
Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries.
Physiol Rev. 2024 Jan 1;104(1):473-532. doi: 10.1152/physrev.00021.2023. Epub 2023 Sep 21.
5
Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.
Cancer Metastasis Rev. 2022 Dec;41(4):803-832. doi: 10.1007/s10555-022-10047-1. Epub 2022 Jun 27.
6
Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity.
Acta Physiol (Oxf). 2022 May;235(1):e13793. doi: 10.1111/apha.13793. Epub 2022 Feb 7.
7
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast Cancer.
Front Oncol. 2021 Nov 3;11:777867. doi: 10.3389/fonc.2021.777867. eCollection 2021.
9
Glucocorticoids and breast cancer risk.
BMC Med. 2021 Aug 2;19(1):187. doi: 10.1186/s12916-021-02036-y.
10
Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Int J Mol Sci. 2021 Apr 24;22(9):4446. doi: 10.3390/ijms22094446.

本文引用的文献

1
The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Mol Cell Biol. 2003 Mar;23(6):1843-55. doi: 10.1128/MCB.23.6.1843-1855.2003.
2
C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation.
Arch Biochem Biophys. 2003 Feb 1;410(1):134-40. doi: 10.1016/s0003-9861(02)00680-x.
3
Parc: a cytoplasmic anchor for p53.
Cell. 2003 Jan 10;112(1):29-40. doi: 10.1016/s0092-8674(02)01255-2.
6
Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.
Mol Cell Biol. 2002 Aug;22(16):5650-61. doi: 10.1128/MCB.22.16.5650-5661.2002.
7
Chromatin remodeling and tissue-selective responses of nuclear hormone receptors.
Biochem Cell Biol. 2002;80(3):343-51. doi: 10.1139/o02-082.
8
Navigating steroid hormone receptors through the nuclear compartment.
Mol Endocrinol. 2002 Jul;16(7):1449-55. doi: 10.1210/mend.16.7.0880.
9
Regulation of DNA replication fork genes by 17beta-estradiol.
Mol Endocrinol. 2002 Jun;16(6):1215-29. doi: 10.1210/mend.16.6.0858.
10
The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors.
EMBO Rep. 2002 Jun;3(6):569-74. doi: 10.1093/embo-reports/kvf114. Epub 2002 May 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验